Skip to content

Study · Non-randomized trial · n = 93 · 2015

4 results

[A role of neuroprotective therapy in the rehabilitation of children with sensorineural hearing loss, IV degrees, after cochlear implanta-tion].

Anosova LV, Levina EA, Chutko LS

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2015

PMID26977915 (opens in a new tab)DOI10.17116/jnevro201511510243-46 (opens in a new tab)PepBankPUB-26977915
Publisher pagePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children after cochlear implantation, auditory perception did not differ between Cerebrolysin and control groups 6 months after implantation.

    In plain wordsIn children after cochlear implantation, auditory perception did not differ between Cerebrolysin and control groups 6 months after implantation.

    Peptide
    Cerebrolysin
    Outcome
    No significant changeAuditory perception
    Study

    n = 93

    Comparator
    Control group without Cerebrolysin
    Outcome group
    Sensory perception · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    No significant between-group differences were found in the level of auditory perception 6 months after CI.
    2 context sentences
    Summary · context
    Authors examined 93 patients, aged from 5 to 8 years.
    Summary · context
    The main group (n=46) received cerebrolysin, the control group was not treated with this drug.
  2. 02HumanNon-randomized trialEfficacy outcome

    In children after cochlear implantation, articulation was higher in the Cerebrolysin group than in the control group.

    In plain wordsIn children after cochlear implantation, articulation was higher with Cerebrolysin than in the control group.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseArticulation
    Study

    n = 93

    Comparator
    Control group without Cerebrolysin
    Outcome group
    Speech and language · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The level of articulation was higher in the main group.
    2 context sentences
    Summary · context
    Authors examined 93 patients, aged from 5 to 8 years.
    Summary · context
    The main group (n=46) received cerebrolysin, the control group was not treated with this drug.
  3. 03HumanNon-randomized trialEfficacy outcome

    In children after cochlear implantation, 23% of the Cerebrolysin group showed the best speech results through better speech communication strategies.

    In plain wordsIn children after cochlear implantation, 23% of the Cerebrolysin group showed the best speech communication results.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableBest speech communication results
    Study

    n = 46

    Outcome group
    Speech and language · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Best results
    23%
    Cerebrolysin main group

    Source sentences

    Summary
    According to the Meaningful Use of Speech Scale, 23% of children of the main group demonstrated the best results due to the better speech communication strategies.
    2 context sentences
    Summary · context
    Authors examined 93 patients, aged from 5 to 8 years.
    Summary · context
    The main group (n=46) received cerebrolysin, the control group was not treated with this drug.
  4. 04HumanNon-randomized trialEfficacy outcome

    In children after cochlear implantation, cognitive functioning improved in those treated with Cerebrolysin.

    In plain wordsIn children after cochlear implantation, cognitive functioning improved in those treated with Cerebrolysin.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseCognitive functioning
    Study

    n = 46

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Cognitive functioning was improved in children treated with cerebrolysin.
    2 context sentences
    Summary · context
    Authors examined 93 patients, aged from 5 to 8 years.
    Summary · context
    The main group (n=46) received cerebrolysin, the control group was not treated with this drug.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.